We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current MBRX market cap is 15.4M. The company's latest EPS is USD -1.5544 and P/E is -0.69.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -8.92M | -6.68M | -6.19M | -7.14M | -6.64M |
| Net Income | -10.27M | -4.97M | -4.32M | -10.59M | -1.88M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -19.74M | -22.97M | -30.64M | -29.63M | -26.64M |
| Net Income | -17.36M | -15.89M | -29.03M | -29.77M | -21.76M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 38.22M | 30.85M | 25.58M | 23.39M | 16.93M |
| Total Liabilities | 12.14M | 9.26M | 7.87M | 15.92M | 10.95M |
| Total Equity | 26.07M | 21.59M | 17.71M | 7.48M | 5.98M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 29.03M | 84.09M | 57.42M | 38.22M | 16.93M |
| Total Liabilities | 11.27M | 5.1M | 5.23M | 12.14M | 10.95M |
| Total Equity | 17.76M | 78.99M | 52.19M | 26.07M | 5.98M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -24.1M | -6.72M | -12.67M | -18.78M | -23.86M |
| Investing | -124k | N/A | -13k | -13k | -13k |
| Financing | 4.65M | N/A | -25k | 4.63M | 4.64M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -17.77M | -18.95M | -27.64M | -24.1M | -23.86M |
| Investing | -374k | -19k | -67k | -124k | -13k |
| Financing | 22.55M | 74.72M | -23k | 4.65M | 4.64M |
| Market Cap | 15.4M |
| Price to Earnings Ratio | -0.69 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 3.5 |
| Price to Book Ratio | 2.51 |
| Dividend Yield | - |
| Shares Outstanding | 14M |
| Average Volume (1 week) | 337.64k |
| Average Volume (1 Month) | 331.79k |
| 52 Week Change | -75.31% |
| 52 Week High | 5.47 |
| 52 Week Low | 0.3975 |
| Spread (Intraday) | 0.08 (7.21%) |
| Company Name | Moleculin Biotech Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.moleculin.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
